Bringing the fundamentals into focus…
Back to Sutro Biopharma, Inc.
How Sutro Biopharma, Inc. stacks up
STRO · against 173 other Healthcare companies of similar size
Overall
14/ 100
Near the bottom of its peers.
Ranked #162 of 174 · scores higher than 6% of peers
Bars: peers in each 10-point band of the overall score11 peers with an overall score of 10–19, including STRO · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around STRO| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 2 | 592M ILS (≈$160M) | 84 | 99 | 99 | 96 | 1 / 2 | |
| 3 | 356M AUD (≈$235M) | 81 | 98 | 35 | 97 | 0 / 2 | |
| 4 | 256M USD | 80 | 98 | 35 | 92 | 0 / 2 | |
| 5 | 1.3B BRL (≈$238M) | 77 | 96 | 72 | 89 | 1 / 2 | |
| 159 | 1.9B CNY (≈$270M) | 17 | 7 | 17 | 32 | 2 / 2 | |
| 159 | 302M USD | 17 | 8 | 31 | 16 | 2 / 2 | |
| 161 | 253M USD | 15 | 8 | 50 | 0 | 2 / 2 | |
| 162 | 271M USD | 14 | 8 | 3 | 7 | 1 / 2 | |
| 162 | 158M USD | 14 | 33 | 10 | 7 | 2 / 2 | |
| 164 | 222M GBP (≈$288M) | 13 | 18 | 17 | 2 / 2 | ||
| 164 | 118M USD | 13 | 8 | 23 | 18 | 2 / 2 | |
| 166 | 35.2B JPY (≈$240M) | 12 | 8 | 7 | 3 | 2 / 2 | |
| 167 | 198M USD | 10 | 8 | 17 | 13 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score